Fig. 2From: Expression and clinical significance of PD-L1 and BRAF expression in nasopharyngeal carcinomaProgression free survival (PFS) and overall survival (OS) for all patients. PFS (a) and OS (b) by PD-L1 expression levels. PFS (c) and OS (d) by BRAF V600E mutationBack to article page